VIOLIN Logo
Cov19VaxKB Banner
Search: for Help
Home
Introduction
Statistics
Authorized Vaccines
Phase III Vaccines
Phase II Vaccines
Phase I Vaccines
Preclinical Vaccines
Vaccine Safety
Vaccine Design
Literature Search
News
Data Submission
Data Exchange
Data Download
Tutorial
Links
Documentation
Updates
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Mar 01, 2025 To Mar 31, 2025 :

SARS-CoV-2 (COVID-19)

  1. Moshirian Farahi SMM, Dalexis RD, Beogo I, Gakima L, Cénat JM. COVID-19 vaccine confidence among parents of racially diverse children aged 0-12 years old in Canada: The role of major experience of racial discrimination, health literacy, and conspiracy beliefs Human vaccines & immunotherapeutics 21(1):2484895 2025 [PMID: 40163329]
  2. Qian C, Johnston KM, Tinajero M, Voss ML, Nam A, Hamilton MA. Characterizing the clinical and economic burden of COVID-19 among individuals with immunocompromising conditions in Ontario, Canada - a matched, population-based observational study Journal of medical economics 28(1):479-493 2025 [PMID: 40160001]
  3. Zhao T, Cai X, Zhang S, Wang M, Chen L, Li X, Wang Z, Wang L, Jiang W, Ha Y, Li H, Liu Y, Lu Q, Cui F. COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting Human vaccines & immunotherapeutics 21(1):2481003 2025 [PMID: 40156199]
  4. Arciniegas JA, Reyes JM, Mendoza CF, Chirila I, Kyaw MH, Escobar O, La Rotta JE, Yarnoff B. Estimating the potential public health and economic impact of vaccination strategies with an adapted vaccine in Colombia using a combined Markov-decision tree model Expert review of vaccines 24(1):242-251 2025 [PMID: 40138189]
  5. Jiang J, Lam KF, Lau EHY, Yin G, Lin Y, Cowling BJ. Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong Expert review of vaccines 24(1):252-260 2025 [PMID: 40137440]
  6. Zhang C, Zhang YQ, Liu RB, Ma YT, Zhao LK, Yin FQ, Tu J, Yao YY. Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies Annals of medicine 57(1):2478319 2025 [PMID: 40135763]
  7. Uthman OA, Katoto PDMC, Anjorin SS, Marais T, Amiche A, Nachega JB. Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic Human vaccines & immunotherapeutics 21(1):2481802 2025 [PMID: 40134119]
  8. Sharma K, Syeda S, Shah SM, Kori SA, Shetty P, Kazi S, Khaiterpal A, Choudhary A, Pathak S, Ahmed S. Overcoming barriers to medical countermeasures: Strengthening global biosecurity Human vaccines & immunotherapeutics 21(1):2483043 2025 [PMID: 40132079]
  9. Doherty TM, Weinberger B, Didierlaurent A, Lambert PH. Age-related changes in the immune system and challenges for the development of age-specific vaccines Annals of medicine 57(1):2477300 2025 [PMID: 40110678]
  10. Roca-Grande J, Mir-Cros A, Muñoz-Almagro C, Lung M, Bellés-Bellés A, Càmara J, Cercenado E, Galán-Ladero MÁ, Martín-Nalda A, Moreno-Mingorance A, Navarro de la Cruz D, Orellana MÁ, Palop B, Pérez-Argüello A, Puigsech-Boixeda G, Quesada MD, Rivera A, Rodriguez-Fernandez A, Ruiz de Gopegui E, Sarvisé C, Soler-Garcia A, Viñado B, Larrosa N, González-López JJ. Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage Emerging microbes & infections 14(1):2482696 2025 [PMID: 40105365]
  11. Liu G, Gonzales MLAM, Chan WH, Memon IA, Alam A, Lee H, Wickramasinghe H, Pham QT, Dayal R, Levin M, Huang YC, Buttery J, Ong-Lim ALT, Kwan MYW. Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region Human vaccines & immunotherapeutics 21(1):2477965 2025 [PMID: 40104999]
  12. Gray Brunton C, Pow J, Carnegie E, Petrova D, Garcia Retamero R, Whittaker A, Todorova I. Commentary and methodological insights: Reaching girls/women, boys/men and vulnerable groups to maximise uptake for the Human papillomavirus vaccine Human vaccines & immunotherapeutics 21(1):2478705 2025 [PMID: 40098461]
  13. Rudolph AE, Al Akoury N, Bogdanenko N, Markus K, Whittle I, Wright O, Haridy H, Spinardi JR, McLaughlin JM, Kyaw MH. Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review Human vaccines & immunotherapeutics 21(1):2474772 2025 [PMID: 40079963]
  14. Zhang X, Fu Y, Chen S, Liu G, Wang Y, He Q, Wang Q, Li N, Wang Z, Chen L, Wang J, Liang Z, Xu M, Mao Q. Exploring the standardization of human nasal antibody measurements Emerging microbes & infections 14(1):2475822 2025 [PMID: 40071971]
  15. Alshagrawi S, Hazazi A. Impact of COVID-19 pandemic on influenza vaccination rates among healthcare workers and the general population in Saudi Arabia: A meta-analysis Human vaccines & immunotherapeutics 21(1):2477954 2025 [PMID: 40068961]
  16. Drobniewski F, Ashmi M, Ahmad R, He C, Bogdanova M, Garbacz A, Moustafa A. Factors influencing vaccine hesitancy among United Kingdom adolescents in a senior high school environment and actions to address it Human vaccines & immunotherapeutics 21(1):2475599 2025 [PMID: 40066692]
  17. Gauna F, Raude J, Khouri C, Cracowski JL, Ward JK. Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review Human vaccines & immunotherapeutics 21(1):2471225 2025 [PMID: 40058398]
  18. Hwang YH, Min DH, Beom Park W. Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection Human vaccines & immunotherapeutics 21(1):2473795 2025 [PMID: 40051347]
  19. Zhang J, Zeng F, Li Y, Mu C, Liu C, Wang L, Peng X, He L, Su Y, Li H, Wang A, Feng L, Gao D, Zhang Z, Xu G, Wang Y, Yue R, Si J, Zheng L, Zhang X, He F, Yi H, Tang Z, Li G, Ma K, Li Q. The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants Human vaccines & immunotherapeutics 21(1):2473183 2025 [PMID: 40045463]
  20. Hong L, Li J, Zeng W, Li Y, Yu C, Zhao S, Chen L, Feng Y. The seroprevalence of adenoviruses since 2000(1) Emerging microbes & infections 14(1):2475831 2025 [PMID: 40035700]
  21. Warang P, Singh G, Moshir M, Binazon O, Laghlali G, Chang LA, Wouters H, Vanhoenacker P, Notebaert M, Elhemdaoui N, Augustynková K, Steeland S, Ulrichts P, Baumeister J, Schotsaert M. Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models Human vaccines & immunotherapeutics 21(1):2470542 2025 [PMID: 40028815]
  22. Lee M, Kwon JS, Kim SH, Woo S, Oh SS. Electrochemical pan-variant detection of SARS-CoV-2 through host cell receptor-mimicking molecular recognition Biosensors & bioelectronics 278:117311 2025 [PMID: 40044551]
  23. Adebiyi BO. Mpox alert: COVID-19's hard-earned lessons put to the test One health (Amsterdam, Netherlands) 20:101003 2025 [PMID: 40129479]
  24. Okubo T, Noy I. Vaccination decisions and social capital in Japan SSM - population health 30:101769 2025 [PMID: 40124530]
  25. Beall RF, Flores Anato JL, D'Souza AG, Velásquez García HA, Ma H, Yang F, Baral SD, Cabaj J, Cooper E, Hollis A, Janjua NZ, Katz A, Leal J, Maheu-Giroux M, May ER, Malikov K, Mishra S, Moloney G, Williamson T. A Canadian multi-province study of COVID-19 vaccine coverage along area-level social determinants in 2021 Public health in practice (Oxford, England) 9:100594 2025 [PMID: 40104250]
  26. Singh S, Liu Y, Burke M, Rayaprolu V, Stein SE, Hasan SS. Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct Journal of structural biology: X 11:100123 2025 [PMID: 40046771]
  27. Hassett-Walker C. Suspicion and other feelings about COVID-19 vaccines and mask-wearing among individuals recovering from substance addiction Public health in practice (Oxford, England) 9:100599 2025 [PMID: 40040672]
  28. Schneider I, Wallrafen-Sam K, Kennedy S, Akiyama MJ, Spaulding AC, Jenness SM. Interventions for SARS-CoV-2 prevention among Jailed adults: A network-based modeling analysis Infectious Disease Modelling 10(2):628-638 2025 [PMID: 40027595]
  29. Grieshaber V, Strumann C, Holzwarth S, Toepfner N, von Meissner WCG, Konstantopoulos N, von Poblotzki M, Hensel KO, Moor MB, Chao CM. The Long-Term Tolerability of BNT162b2 in Children and Adolescents (The CoVacU18 Study) Deutsches Arzteblatt international (Forthcoming) 2025 [PMID: 40101263]
  30. Guzman-Tordecilla DN, Trujillo AJ. Economic and health implications of early COVID-19 lockdown exits: Evidence from a difference-in-differences analysis Social science & medicine (1982) 372:117953 2025 [PMID: 40147334]
  31. Ishigaki H, Itoh Y. Translational research on pandemic virus infection using nonhuman primate models Virology 606:110511 2025 [PMID: 40139071]
  32. Banga Ndzouboukou JL, Kamara AA, Ullah N, Lei Q, Fan XL. A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults Virology 606:110509 2025 [PMID: 40132435]
  33. Movsisyan M, Harutyunyan H, Movsisyan K, Kasparova I, Hakobyan A, Yenkoyan K. Age-related peculiarities of antibody-mediated humoral immune response following SARS-CoV-2 infection Experimental gerontology 203:112735 2025 [PMID: 40120835]
  34. Fortunato C, Gasperini B, Mengarelli Rinaldini D, Peconi C, Lanari A, Sarti D, Pelusi G. Vaccine hesitancy among nurses in the Marche Region Annali di igiene : medicina preventiva e di comunita 37(3):384-389 2025 [PMID: 40110759]
  35. Haddox S, Wu P, Singh S, Qin F, Engel J, Kian A, Ahmad S, Li H, Wu P. Landscape of chimeric RNAs in COVID-19 patient blood Genes & diseases 12(3):101348 2025 [PMID: 40110491]
  36. Lundrigan E, Uguccioni S, Hum C, Ahmed N, Pezacki JP. SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways Virology 606:110493 2025 [PMID: 40073498]
  37. Yuan J, Dong M, Ip DKM, So HC, Liao Q. Dual decision-making routes for COVID-19 and influenza vaccines uptake in parents: A mixed-methods study British journal of health psychology 30(2):e12789 2025 [PMID: 40052507]
  38. Tripathi P, Pandey S, Yadav D, Joshi S. Emergence and evolution of monkeypox virus: Epidemiology, pathology, clinical symptoms, preventative and treatment measures International immunopharmacology 152:114448 2025 [PMID: 40073815]
  39. Liu HL, Lin S, Hung W, Chang DC, Lin SL. A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system Biochemical and biophysical research communications 758:151654 2025 [PMID: 40117978]
  40. Yadav R, Das S, Mukherjee M, Mukherjee S. Probing the nucleobase-specific binding interaction of hydroxychloroquine sulfate with RNA and subsequent sequestration by a water-soluble molecular basket Physical chemistry chemical physics : PCCP 27(14):7365-7374 2025 [PMID: 40125860]
  41. Casalino L, Ramos-Guzmán CA, Amaro RE, Simmerling C, Lodola A, Mulholland AJ, Świderek K, Moliner V. A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats The journal of physical chemistry letters 16(13):3249-3263 2025 [PMID: 40118074]
  42. Talukder A, Chowdhury SM. Mapping Binding Domains of Viral and Allergenic Proteins with Dual-Cleavable Cross-Linking Technology Journal of the American Society for Mass Spectrometry 36(4):721-731 2025 [PMID: 40123104]
  43. Su J, Zhang J, Feng X, Liu J, Gao S, Liu X, Yang M, Chen Z. A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development Molecular therapy : the journal of the American Society of Gene Therapy 33(4):1720-1734 2025 [PMID: 40022448]
  44. Dacso CC. Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged ≥50 y Annals of internal medicine 2025 [PMID: 40163888]
  45. Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A. Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients PNAS nexus 4(4):pgaf085 2025 [PMID: 40160532]
  46. Dey T, Widmer M, Coomarasamy A, Goudar SS, Berrueta M, Coutinho E, Gaaloul ME, Faden RR, Gülmezoglu AM, Justus Hofmeyr G, Knight M, Lamprianou S, Mastroianni AC, Munoz FM, Oladapo OT, Penazzato M, Renaud F, Townsend CL, Bonet M. Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation The Lancet. Global health 13(4):e740-e748 2025 [PMID: 40155111]
  47. Khan HR, Sultan R, Javeed M, Yasmeen H, Arooj I, Janiad S. Functional foods and immune system: A sustainable inhibitory approach against SARS-COV-2 Antiviral therapy 30(2):13596535251322297 2025 [PMID: 40138520]
  48. Lee M, Stein E, Roygardner L. Launching a Novel Program to Improve Pharmacist-Led Immunization Among Older Adults and in Communities With Health Disparities: The Advancing Pharmacist Immunization Initiative The Senior care pharmacist 40(4):167-176 2025 [PMID: 40134044]
  49. Simonis A, Theobald SJ, Koch AE, Mummadavarapu R, Mudler JM, Pouikli A, Göbel U, Acton R, Winter S, Albus A, Holzmann D, Albert MC, Hallek M, Walczak H, Ulas T, Koch M, Tessarz P, Hänsel-Hertsch R, Rybniker J. Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages Molecular systems biology 21(4):341-360 2025 [PMID: 40133533]
  50. DeSilva MB, Haapala J, Vazquez-Benitez G, Daley MF, Lewin B, Klein NP, Liles EG, Jackson LA, Williams JTB, Donahue JG, Katherine Yih W, Kharbanda EO. COVID-19 and Completion of Select Routine Childhood Vaccinations Pediatrics 155(4) 2025 [PMID: 40132643]
  51. Schmid-Küpke N, Kranz L, Rehfuess E, Wichmann O, Neufeind J. [Evaluation of the implementation of the measles and COVID-19 vaccination mandates by public health authorities and health facilities: 2 case studies] Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 68(4):432-443 2025 [PMID: 40131414]
  52. Larsen TG, Ginty JR, Jessen R, Nielsen RB, Jensen A, Botnen AB, Wilkowski B, Rasmussen C, Brødbæk DL, Shaw DS, Benameur E, Rasmussen M, Trebbien R, Mortensen S, Olsen SS, Chong S, Krause TG, Schneider UV, Vangsted AM, Steenhard NR, Møller FT. Virus Monitoring in Denmark: A Community-Based Self-Sampling System to Surveil Respiratory Viruses and Associated Symptoms Journal of medical virology 97(4):e70293 2025 [PMID: 40130741]
  53. Song L, Cui Y, Wang Q, Tan R, Wen Y, Meng C, Jiao X, Pan Z. Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine Viral immunology 38(3):88-95 2025 [PMID: 40127244]
  54. Lin EP, Hsu CY, Mishra S, Griffiths EA, Segal BH, Hwang C, Singh SRK, Balanchivadze N, Jani C, Mariano MG, Bhatt PS, Vieira K, Yu PP, Oligino EJ, Wise-Draper T, Ferrara EK, McKay RR, Nonato TK, Labaki C, Saad E, Saliby RM, Morgans AK, Nohria A, Puc M, Accordino MK, Bodin BE, Nanchal R, Singh H, Berg S, Mavromatis B, McManus HD, Halabi S, Choueiri TK, Warner JL, Shyr Y. Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection Lancet regional health. Americas 44:101038 2025 [PMID: 40124588]
  55. Hall TM, Attwell K, Morgan VA, Hincks S, Waterreus A. Exploring barriers to the COVID-19 vaccine in people with psychoses in Western Australia Preventive medicine reports 52:103025 2025 [PMID: 40124135]
  56. Zabalza A, Thompson A, Rotstein DL, Bar-Or A, Montalban X. Multiple sclerosis and COVID-19: interactions and unresolved issues The Lancet. Neurology 24(4):361-370 2025 [PMID: 40120619]
  57. Laake JH, Hagen M, Aavitsland P, Buanes EA, Fjone KS, Kvåle R, Olsen BF, Hofsø K. COVID-19 in Norwegian ICUs 2020-2023: Patient characteristics, management, and outcomes-A nationwide prospective observational study Acta anaesthesiologica Scandinavica 69(4):e70027 2025 [PMID: 40114460]
  58. Gambari R, Papi C, Gasparello J, Agostinelli E, Finotti A. Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene Experimental and therapeutic medicine 29(4):85 2025 [PMID: 40084194]
  59. Moreira Puga MA, Dias de Oliveira R, Vieira da Silva P, Charu V, Hedlin H, Lu D, Zhang A, Shaw B, Rosser JI, Seidman JC, Carter AS, Qamar FN, Luby SP, Garrett DO, Croda J. Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil Lancet regional health. Americas 44:101031 2025 [PMID: 40083966]
  60. Rowe SL, Sullivan SG, Muñoz FM, Coates MM, Agnew B, Arah OA, Regan AK. COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects Pediatrics 155(4) 2025 [PMID: 40081452]
  61. Fierlbeck K, Gautier L, Usher S, Allin S, Sriram V, Berman P. Testing "the science": A comparative analysis of COVID-19 testing policy across four Canadian provinces Social science & medicine (1982) 371:117880 2025 [PMID: 40081167]
  62. Cilloniz C, Videla AJ, Pulido L, Uy-King MJ. Viral community-acquired pneumonia: what's new since COVID-19 emerged? Expert review of respiratory medicine 19(4):347-362 2025 [PMID: 40077864]
  63. Brown KM, Courtot B, Porter Z, Hinojosa S. Better Together: Implementation of a Public Health Learning Community During the COVID-19 Pandemic American journal of public health 115(4):469-472 2025 [PMID: 40073360]
  64. White BK, Burns SK, Carson J, Scott JA. 'I'm glad my baby has weaned so I don't need to make that decision.' Understanding breastfeeding-related COVID-19 vaccine narratives on social media Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals 36(2):e946 2025 [PMID: 40069117]
  65. Rodriguez-Idiazabal L, Quintana JM, Garcia-Asensio J, Legarreta MJ, Larrea N, Barrio I. Clinically meaningful phenotypes among SARS-CoV-2 reinfections: Informing prevention strategies for future pandemics Preventive medicine 193:108259 2025 [PMID: 40064450]
  66. Jones MU, Richard SA, Malloy AMW, Colombo RE, May J, Saunders D, Lindholm DA, Ganesan A, Sablak C, Hickey PW, Dobson CP, Pollett SD, Flanagan R. Clinical Characteristics and Outcomes of Cardiac Findings in Young Persons Following SARS-CoV-2 Infection The Pediatric infectious disease journal 44(4):342-345 2025 [PMID: 40063968]
  67. Adler AL, Waghmare A, Lacombe K, Dickerson JA, L Greninger A, Briggs Hagen M, Pringle K, Fairlie T, Midgely CM, Englund JA. Seroprevalence of SARS-CoV-2 IgG antibodies in children seeking medical care in Seattle, WA June 2020 to December 2022 Microbiology spectrum 13(4):e0262524 2025 [PMID: 40062892]
  68. Kida I, Tamura T, Kuroda Y, Fukuhara T, Maeda K, Matsuno K. Application of versatile reverse genetics system for feline coronavirus Microbiology spectrum 13(4):e0269224 2025 [PMID: 40062768]
  69. Cox SN, Chow EJ, Rolfes MA, Mosites E, Sharma M, Chu HY, Zimmermann M. Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis AJPM focus 4(2):100307 2025 [PMID: 40061153]
  70. Chen T, Wang Y, Xie R, Dong L, Chen J, Yang L. Global Research on the Treatment of Cancer Patients During the COVID-19 Pandemic: Visualisation and Bibliometric Analysis Clinical oncology (Royal College of Radiologists (Great Britain)) 40:103774 2025 [PMID: 40056854]
  71. Dhawan M, Thakur N, Sharma M, Rabaan AA. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 185:117936 2025 [PMID: 40056829]
  72. Xu H, Yang M, Liu S, Zheng F, Li Y, Li Y, Wang C, Qian J, Zhao Y, Yang S, Sun M, Song X, Guo R, Zhou J, Fan B, Li B. Constructions and immunogenicity evaluations of two porcine epdemic diarrhea virus-like particle vaccines Veterinary microbiology 303:110451 2025 [PMID: 40048881]
  73. Tran-Kiem C, Paredes MI, Perofsky AC, Frisbie LA, Xie H, Kong K, Weixler A, Greninger AL, Roychoudhury P, Peterson JM, Delgado A, Halstead H, MacKellar D, Dykema P, Gamboa L, Frazar CD, Ryke E, Stone J, Reinhart D, Starita L, Thibodeau A, Yun C, Aragona F, Black A, Viboud C, Bedford T. Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences Nature 640(8057):176-185 2025 [PMID: 40044856]
  74. Kocharovskaya MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, Grafskaia EN, Lyukmanova EN, Kirpichnikov MP, Shenkarev ZO. Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987 Biochemical and biophysical research communications 755:151558 2025 [PMID: 40043614]
  75. Gottlieb M, Yu H, Chen J, Spatz ES, Gentile NL, Geyer RE, Santangelo M, Malicki C, Gatling K, Saydah S, O'Laughlin KN, Stephens KA, Elmore JG, Wisk LE, L'Hommedieu M, Rodriguez RM, Montoy JCC, Wang RC, Rising KL, Kean E, Dyal JW, Hill MJ, Venkatesh AK, Weinstein RA. Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group Lancet regional health. Americas 44:101026 2025 [PMID: 40040820]
  76. Kandaswamy S, Masterson E, Blanco R, Lantis P, Dawson TE, Ray E, Bryant C, Iyer S, Shane AL, Jernigan S, Orenstein EW. Evaluation of Influenza Vaccine Clinical Decision Support Systems Bundle for Hospitalized Children Hospital pediatrics 15(4):351-359 2025 [PMID: 40037515]
  77. Benlarbi M, Kenfack DD, Dionne K, Côté-Chenette M, Beaudoin-Bussières G, Bélanger É, Ding S, Goni OH, Ngoume YF, Tauzin A, Medjahed H, Ghedin E, Duerr R, Finzi A, Tongo M. Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon Virology 605:110467 2025 [PMID: 40037139]
  78. Klimek P. [Cost effectiveness of vaccinations: on the complexity of health economic analyses of influenza, SARS-CoV-2 and RSV vaccination] Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 68(4):451-457 2025 [PMID: 40035792]
  79. Kurdi A, Albutti A, Darweesh O, Amen KM, Baker K, Karwi H, Godman B. Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals Expert review of clinical pharmacology 18(4):237-246 2025 [PMID: 40022595]
  80. Khalifa AZ, Perrie Y, Shahiwala A. Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines Expert opinion on drug delivery 22(4):583-597 2025 [PMID: 40021342]
  81. Lam JH, Sinsinbar G, Loo SY, Chia TW, Lee YJ, Fong JY, Chia YE, Penna RR, Liu S, Pascolo S, Schultheis K, Nallani M. Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery Biomacromolecules 2025 [PMID: 40163903]
  82. Wang M, Patsenker J, Li H, Kluger Y, Kleinstein SH. Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction PLoS computational biology 21(3):e1012153 2025 [PMID: 40163503]
  83. Kusunoki T, Tsubata N, Iijima N, Mitsugi S, Nagasaka T, Senga T, Ichie R, Okamoto T. Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients Microbiology spectrum :e0002125 2025 [PMID: 40162748]
  84. Sterian M, Naganathan T, Corrin T, Waddell LA. Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review Epidemiology and infection :1-46 2025 [PMID: 40159916]
  85. Campman SL, Boyd A, Schinkel J, Coyer L, Agyemang C, Galenkamp H, Koopman ADM, Chilunga FP, Koopsen J, Zwinderman AH, Jurriaans S, Stronks K, Prins M. SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM Epidemiology and infection 153:e53 2025 [PMID: 40159907]
  86. Alpaydin Baslo S, Yuksel B, Baytekin I, Incesoy AC, Kara ES, Koseoglu M, Teker S, Cengizler B, Oktelik FB, Sen A, Atakli D, Deniz G, Soysal A. Antibodies against SARS-CoV-2 in cerebrospinal fluid: Clinical features and laboratory findings of hospitalized patients with neurologic symptoms in the pandemic era Ideggyogyaszati szemle 78(3-04):136-144 2025 [PMID: 40163003]
  87. Letscher H, Guilligay D, Effantin G, Amen A, Sulbaran G, Burger JA, Bossevot L, Junges L, Leonec M, Morin J, Van Tilbeurgh M, Hérate C, Gallouët AS, Relouzat F, van der Werf S, Cavarelli M, Dereuddre-Bosquet N, van Gils MJ, Sanders RW, Poignard P, Le Grand R, Weissenhorn W. RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques NPJ vaccines 10(1):63 2025 [PMID: 40159504]
  88. Perrett SE, Thomas DR, Saville CWN. Social capital and COVID-19 vaccination in prisons: a survey of attitudes, beliefs, and motivations Journal of public health (Oxford, England) 2025 [PMID: 40158197]
  89. Huang Z, Gao C, Huang S, Lin S, Zhang W, You J, Chen X, Zhou P, Zhang G, Gong L. The alpha-coronavirus E protein inhibits the JAK-STAT pathway signaling by triggering STAT2 degradation through OPTN- and NBR1-mediated selective autophagy Autophagy :1-18 2025 [PMID: 40091174]
  90. Jiang J, Lam KF, Lau EHY, Yin G, Lin Y, Cowling BJ. Estimation of trajectory of COVID-19 vaccines effectiveness against infection Vaccine 55:127067 2025 [PMID: 40158307]
  91. Newbern EC, Shoaibi A, Haynes K, Blacketer C, Willame C, DeFalco F, Rao GA, Davis K, Velarde LA, Praet N, Makadia R, Xu Y, Ryan P, Schuemie M. A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine Vaccine 55:127044 2025 [PMID: 40158304]
  92. Li S, Yu J, Xiao C, Li Y. Immunoinformatics method to design universal multi-epitope nanoparticle vaccine for TGEV S protein Scientific reports 15(1):10931 2025 [PMID: 40158011]
  93. Sahin F, Atasoy BT, Yalcin S, Bitirim VC. Membrane-targeted immunogenic compositions using exosome mimetic approach for vaccine development against SARS-CoV-2 and other pathogens Scientific reports 15(1):10899 2025 [PMID: 40157987]
  94. Thepveera S, Charuvanij S, Sukharomana M, Thunsiribuddhichai Y, Lomjansook K, Chaiyapak T, Pattaragarn A, Sumboonnanoda A, Piyaphanee N. Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus Lupus :9612033251331244 2025 [PMID: 40156281]
  95. Cénat JM, Moshirian Farahi SMM, Dalexis RD, Xu Y, Beogo I. Vaccine hesitancy among racially diverse parents in Canada: The important role of health literacy, conspiracy beliefs and racial discrimination Vaccine 55:127049 2025 [PMID: 40158306]
  96. Nuñez-Franz L, Rubilar P, Apablaza M, Canales L, Cortés LJ, Molina X, Said M, Olivares K, Correa J, Ramírez-Santana M. Population-based seroprevalence survey: post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile BMC public health 25(1):1176 2025 [PMID: 40155965]
  97. Morelli T, Freeman A, Staples KJ, Wilkinson TMA. Hidden in plain sight: the impact of human rhinovirus infection in adults Respiratory research 26(1):120 2025 [PMID: 40155903]
  98. Jafari N, Akbari H, Maghsoodi A, Sarbakhsh P. The attitude of the unvaccinated children's parents toward pediatric COVID-19 vaccination in Tabriz, Iran BMC pediatrics 25(1):248 2025 [PMID: 40155899]
  99. Gholami Z, Mohseni M, Nasab PA. Comparing the maternal and neonatal outcomes in vaccinated and unvaccinated pregnant women against COVID-19: a retrospective cohort study BMC pregnancy and childbirth 25(1):367 2025 [PMID: 40155874]
  100. Guillén-Teruel A, Mellina-Andreu JL, Reina G, González-Billalabeitia E, Rodriguez-Iborra R, Palma J, Botía JA, Cisterna-García A. Identifying risk factors and predicting long COVID in a Spanish cohort Scientific reports 15(1):10758 2025 [PMID: 40155409]

See more by clicking HERE

Coronavirus

  1. Moshirian Farahi SMM, Dalexis RD, Beogo I, Gakima L, Cénat JM. COVID-19 vaccine confidence among parents of racially diverse children aged 0-12 years old in Canada: The role of major experience of racial discrimination, health literacy, and conspiracy beliefs Human vaccines & immunotherapeutics 21(1):2484895 2025 [PMID: 40163329]
  2. Qian C, Johnston KM, Tinajero M, Voss ML, Nam A, Hamilton MA. Characterizing the clinical and economic burden of COVID-19 among individuals with immunocompromising conditions in Ontario, Canada - a matched, population-based observational study Journal of medical economics 28(1):479-493 2025 [PMID: 40160001]
  3. Zhao T, Cai X, Zhang S, Wang M, Chen L, Li X, Wang Z, Wang L, Jiang W, Ha Y, Li H, Liu Y, Lu Q, Cui F. COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting Human vaccines & immunotherapeutics 21(1):2481003 2025 [PMID: 40156199]
  4. Arciniegas JA, Reyes JM, Mendoza CF, Chirila I, Kyaw MH, Escobar O, La Rotta JE, Yarnoff B. Estimating the potential public health and economic impact of vaccination strategies with an adapted vaccine in Colombia using a combined Markov-decision tree model Expert review of vaccines 24(1):242-251 2025 [PMID: 40138189]
  5. Jiang J, Lam KF, Lau EHY, Yin G, Lin Y, Cowling BJ. Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong Expert review of vaccines 24(1):252-260 2025 [PMID: 40137440]
  6. Zhang C, Zhang YQ, Liu RB, Ma YT, Zhao LK, Yin FQ, Tu J, Yao YY. Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies Annals of medicine 57(1):2478319 2025 [PMID: 40135763]
  7. Uthman OA, Katoto PDMC, Anjorin SS, Marais T, Amiche A, Nachega JB. Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic Human vaccines & immunotherapeutics 21(1):2481802 2025 [PMID: 40134119]
  8. Sharma K, Syeda S, Shah SM, Kori SA, Shetty P, Kazi S, Khaiterpal A, Choudhary A, Pathak S, Ahmed S. Overcoming barriers to medical countermeasures: Strengthening global biosecurity Human vaccines & immunotherapeutics 21(1):2483043 2025 [PMID: 40132079]
  9. Doherty TM, Weinberger B, Didierlaurent A, Lambert PH. Age-related changes in the immune system and challenges for the development of age-specific vaccines Annals of medicine 57(1):2477300 2025 [PMID: 40110678]
  10. Liu G, Gonzales MLAM, Chan WH, Memon IA, Alam A, Lee H, Wickramasinghe H, Pham QT, Dayal R, Levin M, Huang YC, Buttery J, Ong-Lim ALT, Kwan MYW. Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region Human vaccines & immunotherapeutics 21(1):2477965 2025 [PMID: 40104999]
  11. Rudolph AE, Al Akoury N, Bogdanenko N, Markus K, Whittle I, Wright O, Haridy H, Spinardi JR, McLaughlin JM, Kyaw MH. Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review Human vaccines & immunotherapeutics 21(1):2474772 2025 [PMID: 40079963]
  12. Zhang X, Fu Y, Chen S, Liu G, Wang Y, He Q, Wang Q, Li N, Wang Z, Chen L, Wang J, Liang Z, Xu M, Mao Q. Exploring the standardization of human nasal antibody measurements Emerging microbes & infections 14(1):2475822 2025 [PMID: 40071971]
  13. Alshagrawi S, Hazazi A. Impact of COVID-19 pandemic on influenza vaccination rates among healthcare workers and the general population in Saudi Arabia: A meta-analysis Human vaccines & immunotherapeutics 21(1):2477954 2025 [PMID: 40068961]
  14. Gauna F, Raude J, Khouri C, Cracowski JL, Ward JK. Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review Human vaccines & immunotherapeutics 21(1):2471225 2025 [PMID: 40058398]
  15. Hwang YH, Min DH, Beom Park W. Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection Human vaccines & immunotherapeutics 21(1):2473795 2025 [PMID: 40051347]
  16. Zhang J, Zeng F, Li Y, Mu C, Liu C, Wang L, Peng X, He L, Su Y, Li H, Wang A, Feng L, Gao D, Zhang Z, Xu G, Wang Y, Yue R, Si J, Zheng L, Zhang X, He F, Yi H, Tang Z, Li G, Ma K, Li Q. The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants Human vaccines & immunotherapeutics 21(1):2473183 2025 [PMID: 40045463]
  17. Hong L, Li J, Zeng W, Li Y, Yu C, Zhao S, Chen L, Feng Y. The seroprevalence of adenoviruses since 2000(1) Emerging microbes & infections 14(1):2475831 2025 [PMID: 40035700]
  18. Warang P, Singh G, Moshir M, Binazon O, Laghlali G, Chang LA, Wouters H, Vanhoenacker P, Notebaert M, Elhemdaoui N, Augustynková K, Steeland S, Ulrichts P, Baumeister J, Schotsaert M. Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models Human vaccines & immunotherapeutics 21(1):2470542 2025 [PMID: 40028815]
  19. Lee M, Kwon JS, Kim SH, Woo S, Oh SS. Electrochemical pan-variant detection of SARS-CoV-2 through host cell receptor-mimicking molecular recognition Biosensors & bioelectronics 278:117311 2025 [PMID: 40044551]
  20. Singh S, Liu Y, Burke M, Rayaprolu V, Stein SE, Hasan SS. Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct Journal of structural biology: X 11:100123 2025 [PMID: 40046771]
  21. Guzman-Tordecilla DN, Trujillo AJ. Economic and health implications of early COVID-19 lockdown exits: Evidence from a difference-in-differences analysis Social science & medicine (1982) 372:117953 2025 [PMID: 40147334]
  22. Ishigaki H, Itoh Y. Translational research on pandemic virus infection using nonhuman primate models Virology 606:110511 2025 [PMID: 40139071]
  23. Banga Ndzouboukou JL, Kamara AA, Ullah N, Lei Q, Fan XL. A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults Virology 606:110509 2025 [PMID: 40132435]
  24. Movsisyan M, Harutyunyan H, Movsisyan K, Kasparova I, Hakobyan A, Yenkoyan K. Age-related peculiarities of antibody-mediated humoral immune response following SARS-CoV-2 infection Experimental gerontology 203:112735 2025 [PMID: 40120835]
  25. Haddox S, Wu P, Singh S, Qin F, Engel J, Kian A, Ahmad S, Li H, Wu P. Landscape of chimeric RNAs in COVID-19 patient blood Genes & diseases 12(3):101348 2025 [PMID: 40110491]
  26. Lundrigan E, Uguccioni S, Hum C, Ahmed N, Pezacki JP. SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways Virology 606:110493 2025 [PMID: 40073498]
  27. Yuan J, Dong M, Ip DKM, So HC, Liao Q. Dual decision-making routes for COVID-19 and influenza vaccines uptake in parents: A mixed-methods study British journal of health psychology 30(2):e12789 2025 [PMID: 40052507]
  28. Liu HL, Lin S, Hung W, Chang DC, Lin SL. A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system Biochemical and biophysical research communications 758:151654 2025 [PMID: 40117978]
  29. Yadav R, Das S, Mukherjee M, Mukherjee S. Probing the nucleobase-specific binding interaction of hydroxychloroquine sulfate with RNA and subsequent sequestration by a water-soluble molecular basket Physical chemistry chemical physics : PCCP 27(14):7365-7374 2025 [PMID: 40125860]
  30. Casalino L, Ramos-Guzmán CA, Amaro RE, Simmerling C, Lodola A, Mulholland AJ, Świderek K, Moliner V. A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats The journal of physical chemistry letters 16(13):3249-3263 2025 [PMID: 40118074]
  31. Talukder A, Chowdhury SM. Mapping Binding Domains of Viral and Allergenic Proteins with Dual-Cleavable Cross-Linking Technology Journal of the American Society for Mass Spectrometry 36(4):721-731 2025 [PMID: 40123104]
  32. Su J, Zhang J, Feng X, Liu J, Gao S, Liu X, Yang M, Chen Z. A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development Molecular therapy : the journal of the American Society of Gene Therapy 33(4):1720-1734 2025 [PMID: 40022448]
  33. Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A. Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients PNAS nexus 4(4):pgaf085 2025 [PMID: 40160532]
  34. Khan HR, Sultan R, Javeed M, Yasmeen H, Arooj I, Janiad S. Functional foods and immune system: A sustainable inhibitory approach against SARS-COV-2 Antiviral therapy 30(2):13596535251322297 2025 [PMID: 40138520]
  35. Simonis A, Theobald SJ, Koch AE, Mummadavarapu R, Mudler JM, Pouikli A, Göbel U, Acton R, Winter S, Albus A, Holzmann D, Albert MC, Hallek M, Walczak H, Ulas T, Koch M, Tessarz P, Hänsel-Hertsch R, Rybniker J. Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages Molecular systems biology 21(4):341-360 2025 [PMID: 40133533]
  36. Schmid-Küpke N, Kranz L, Rehfuess E, Wichmann O, Neufeind J. [Evaluation of the implementation of the measles and COVID-19 vaccination mandates by public health authorities and health facilities: 2 case studies] Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 68(4):432-443 2025 [PMID: 40131414]
  37. Larsen TG, Ginty JR, Jessen R, Nielsen RB, Jensen A, Botnen AB, Wilkowski B, Rasmussen C, Brødbæk DL, Shaw DS, Benameur E, Rasmussen M, Trebbien R, Mortensen S, Olsen SS, Chong S, Krause TG, Schneider UV, Vangsted AM, Steenhard NR, Møller FT. Virus Monitoring in Denmark: A Community-Based Self-Sampling System to Surveil Respiratory Viruses and Associated Symptoms Journal of medical virology 97(4):e70293 2025 [PMID: 40130741]
  38. Song L, Cui Y, Wang Q, Tan R, Wen Y, Meng C, Jiao X, Pan Z. Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine Viral immunology 38(3):88-95 2025 [PMID: 40127244]
  39. Hall TM, Attwell K, Morgan VA, Hincks S, Waterreus A. Exploring barriers to the COVID-19 vaccine in people with psychoses in Western Australia Preventive medicine reports 52:103025 2025 [PMID: 40124135]
  40. Zabalza A, Thompson A, Rotstein DL, Bar-Or A, Montalban X. Multiple sclerosis and COVID-19: interactions and unresolved issues The Lancet. Neurology 24(4):361-370 2025 [PMID: 40120619]
  41. Gambari R, Papi C, Gasparello J, Agostinelli E, Finotti A. Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene Experimental and therapeutic medicine 29(4):85 2025 [PMID: 40084194]
  42. Fierlbeck K, Gautier L, Usher S, Allin S, Sriram V, Berman P. Testing "the science": A comparative analysis of COVID-19 testing policy across four Canadian provinces Social science & medicine (1982) 371:117880 2025 [PMID: 40081167]
  43. Cilloniz C, Videla AJ, Pulido L, Uy-King MJ. Viral community-acquired pneumonia: what's new since COVID-19 emerged? Expert review of respiratory medicine 19(4):347-362 2025 [PMID: 40077864]
  44. Brown KM, Courtot B, Porter Z, Hinojosa S. Better Together: Implementation of a Public Health Learning Community During the COVID-19 Pandemic American journal of public health 115(4):469-472 2025 [PMID: 40073360]
  45. White BK, Burns SK, Carson J, Scott JA. 'I'm glad my baby has weaned so I don't need to make that decision.' Understanding breastfeeding-related COVID-19 vaccine narratives on social media Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals 36(2):e946 2025 [PMID: 40069117]
  46. Rodriguez-Idiazabal L, Quintana JM, Garcia-Asensio J, Legarreta MJ, Larrea N, Barrio I. Clinically meaningful phenotypes among SARS-CoV-2 reinfections: Informing prevention strategies for future pandemics Preventive medicine 193:108259 2025 [PMID: 40064450]
  47. Jones MU, Richard SA, Malloy AMW, Colombo RE, May J, Saunders D, Lindholm DA, Ganesan A, Sablak C, Hickey PW, Dobson CP, Pollett SD, Flanagan R. Clinical Characteristics and Outcomes of Cardiac Findings in Young Persons Following SARS-CoV-2 Infection The Pediatric infectious disease journal 44(4):342-345 2025 [PMID: 40063968]
  48. Adler AL, Waghmare A, Lacombe K, Dickerson JA, L Greninger A, Briggs Hagen M, Pringle K, Fairlie T, Midgely CM, Englund JA. Seroprevalence of SARS-CoV-2 IgG antibodies in children seeking medical care in Seattle, WA June 2020 to December 2022 Microbiology spectrum 13(4):e0262524 2025 [PMID: 40062892]
  49. Kida I, Tamura T, Kuroda Y, Fukuhara T, Maeda K, Matsuno K. Application of versatile reverse genetics system for feline coronavirus Microbiology spectrum 13(4):e0269224 2025 [PMID: 40062768]
  50. Chen T, Wang Y, Xie R, Dong L, Chen J, Yang L. Global Research on the Treatment of Cancer Patients During the COVID-19 Pandemic: Visualisation and Bibliometric Analysis Clinical oncology (Royal College of Radiologists (Great Britain)) 40:103774 2025 [PMID: 40056854]
  51. Dhawan M, Thakur N, Sharma M, Rabaan AA. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 185:117936 2025 [PMID: 40056829]
  52. Xu H, Yang M, Liu S, Zheng F, Li Y, Li Y, Wang C, Qian J, Zhao Y, Yang S, Sun M, Song X, Guo R, Zhou J, Fan B, Li B. Constructions and immunogenicity evaluations of two porcine epdemic diarrhea virus-like particle vaccines Veterinary microbiology 303:110451 2025 [PMID: 40048881]
  53. Tran-Kiem C, Paredes MI, Perofsky AC, Frisbie LA, Xie H, Kong K, Weixler A, Greninger AL, Roychoudhury P, Peterson JM, Delgado A, Halstead H, MacKellar D, Dykema P, Gamboa L, Frazar CD, Ryke E, Stone J, Reinhart D, Starita L, Thibodeau A, Yun C, Aragona F, Black A, Viboud C, Bedford T. Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences Nature 640(8057):176-185 2025 [PMID: 40044856]
  54. Kocharovskaya MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, Grafskaia EN, Lyukmanova EN, Kirpichnikov MP, Shenkarev ZO. Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987 Biochemical and biophysical research communications 755:151558 2025 [PMID: 40043614]
  55. Benlarbi M, Kenfack DD, Dionne K, Côté-Chenette M, Beaudoin-Bussières G, Bélanger É, Ding S, Goni OH, Ngoume YF, Tauzin A, Medjahed H, Ghedin E, Duerr R, Finzi A, Tongo M. Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon Virology 605:110467 2025 [PMID: 40037139]
  56. Klimek P. [Cost effectiveness of vaccinations: on the complexity of health economic analyses of influenza, SARS-CoV-2 and RSV vaccination] Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 68(4):451-457 2025 [PMID: 40035792]
  57. Khalifa AZ, Perrie Y, Shahiwala A. Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines Expert opinion on drug delivery 22(4):583-597 2025 [PMID: 40021342]
  58. Alpaydin Baslo S, Yuksel B, Baytekin I, Incesoy AC, Kara ES, Koseoglu M, Teker S, Cengizler B, Oktelik FB, Sen A, Atakli D, Deniz G, Soysal A. Antibodies against SARS-CoV-2 in cerebrospinal fluid: Clinical features and laboratory findings of hospitalized patients with neurologic symptoms in the pandemic era Ideggyogyaszati szemle 78(3-04):136-144 2025 [PMID: 40163003]
  59. Huang Z, Gao C, Huang S, Lin S, Zhang W, You J, Chen X, Zhou P, Zhang G, Gong L. The alpha-coronavirus E protein inhibits the JAK-STAT pathway signaling by triggering STAT2 degradation through OPTN- and NBR1-mediated selective autophagy Autophagy :1-18 2025 [PMID: 40091174]
  60. Newbern EC, Shoaibi A, Haynes K, Blacketer C, Willame C, DeFalco F, Rao GA, Davis K, Velarde LA, Praet N, Makadia R, Xu Y, Ryan P, Schuemie M. A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine Vaccine 55:127044 2025 [PMID: 40158304]
  61. Li S, Yu J, Xiao C, Li Y. Immunoinformatics method to design universal multi-epitope nanoparticle vaccine for TGEV S protein Scientific reports 15(1):10931 2025 [PMID: 40158011]
  62. Sahin F, Atasoy BT, Yalcin S, Bitirim VC. Membrane-targeted immunogenic compositions using exosome mimetic approach for vaccine development against SARS-CoV-2 and other pathogens Scientific reports 15(1):10899 2025 [PMID: 40157987]
  63. Thepveera S, Charuvanij S, Sukharomana M, Thunsiribuddhichai Y, Lomjansook K, Chaiyapak T, Pattaragarn A, Sumboonnanoda A, Piyaphanee N. Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus Lupus :9612033251331244 2025 [PMID: 40156281]
  64. Nuñez-Franz L, Rubilar P, Apablaza M, Canales L, Cortés LJ, Molina X, Said M, Olivares K, Correa J, Ramírez-Santana M. Population-based seroprevalence survey: post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile BMC public health 25(1):1176 2025 [PMID: 40155965]
  65. Gholami Z, Mohseni M, Nasab PA. Comparing the maternal and neonatal outcomes in vaccinated and unvaccinated pregnant women against COVID-19: a retrospective cohort study BMC pregnancy and childbirth 25(1):367 2025 [PMID: 40155874]
  66. Guillén-Teruel A, Mellina-Andreu JL, Reina G, González-Billalabeitia E, Rodriguez-Iborra R, Palma J, Botía JA, Cisterna-García A. Identifying risk factors and predicting long COVID in a Spanish cohort Scientific reports 15(1):10758 2025 [PMID: 40155409]
  67. Arciniegas J, Reyes JM, Bolaños-López J, Mendoza CF, Spinardi J, Yang J, Maleki F, Gonzalez FJ, Bello C, Herrera AC, Escobar O, Rubio AC, García M, Pérez LE, La Rotta J, Kyaw M. Clinical characteristics and burden of COVID-19 in children and adolescents in Colombia: a retrospective database analysis BMJ paediatrics open 9(1) 2025 [PMID: 40154988]
  68. Zhu F, Rajan S, Hayes CF, Kwong KY, Goncalves AR, Zemla AT, Lau EY, Zhang Y, Cai Y, Goforth JW, Landajuela M, Gilchuk P, Kierny M, Dippel A, Amofah B, Kaplan G, Cadevilla Peano V, Morehouse C, Sparklin B, Gopalakrishnan V, Tuffy KM, Nguyen A, Beloor J, Kijak G, Liu C, Dijokaite-Guraliuc A, Mongkolsapaya J, Screaton GR, Petersen BK, Desautels TA, Bennett D, Conti S, Segelke BW, Arrildt KT, Kaul S, Grzesiak EA, da Silva FL, Bates TW, Earnhart CG, Hopkins S, Sundaram S, Esser MT, Francica JR, Faissol DM. Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape Science advances 11(13):eadu0718 2025 [PMID: 40153503]
  69. Fan R, Liang Q, Sui Y, Yang Y, Yuan X. The next viral pandemic-where do we stand? Folia microbiologica 2025 [PMID: 40153131]
  70. Park SH, Shah IR, Jhumur NC, Mo Y, Tendolkar S, Lallow EO, Shan JW, Zahn JD, Maslow JN, Pelegri AA, Lin H, Shreiber DI, Singer JP. Microneedle arrays coated with Middle East respiratory syndrome coronavirus DNA vaccine via electrospray deposition Soft matter 2025 [PMID: 40151993]
  71. Çetinkaya E, Taş A. COVID-19 Infection, Vaccination, and Severe Coronary Artery Disease in Türkiye: A Retrospective Analysis Anatolian journal of cardiology 2025 [PMID: 40151843]
  72. Ali SA, Chen YL, Tseng HS, Ayalew H, She JW, Gautam B, Tu HL, Hsiao YS, Yu HH. Poly(3,4-ethylenedioxythiophene) Nanorod Arrays-Based Organic Electrochemical Transistor for SARS-CoV-2 Spike Protein Detection in Artificial Saliva ACS sensors 10(3):2007-2018 2025 [PMID: 40080450]
  73. Trier NH, Zivlaei N, Ostrowski SR, Sørensen E, Larsen M, Slibinskas R, Ciplys E, Frederiksen JL, Houen G. Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals Immunology letters :107004 2025 [PMID: 40157431]
  74. Hwang MK, Dua H, Mulligan AM, Escallon J. Seven-month persistence of COVID-19 vaccine-induced lymphadenopathy: a case report Journal of medical case reports 19(1):143 2025 [PMID: 40148999]
  75. Maiga AI, Kodio A, Ouedraogo SA, Baldé A, Dembele P, Traore FT, Dolo O, Togo J, Coulibaly YA, Sylla M, Murphy RL, Marcelin AG, Calvez V, Diakité AA, Todesco E. Seroprevalence of anti-SARS-CoV-2 IgG antibodies among children attending the pediatric hospital in Bamako, Mali (BamaCoV-Kids Study) BMC infectious diseases 25(1):429 2025 [PMID: 40148768]
  76. Awundja BMA, Tchuente BRT, Hagbe VP, Nnanga LS, Kamdem L, Ekedjoum DYE, Roger OMH, Maguerrite B, Patricia D, Ndanji JA, Mbah LJN, Lumngwena EN, Bongue B, Ngondi JL. Biological profile and risk factors of mortality in COVID-19 patients at Adlucem hospital in Banka-Bafang, Cameroon: a cross-sectional study BMC infectious diseases 25(1):420 2025 [PMID: 40141010]
  77. Embrett M, Carson A, Sim M, Conway A, Moore E, Hancock K, Bielska I. Building Resilient and Responsive Health Research Systems:Responses and the Lessons Learned from the COVID-19 Pandemic Health research policy and systems 23(1):38 2025 [PMID: 40140981]
  78. Sikiru NA, Al-Mustapha AI, Oyewo M, Sani BS, Habibah A, Alikinla MM, Elelu N. A cross-sectional survey of COVID-19 testing status among vaccine recipients in Gombe State, North-Eastern Nigeria BMC public health 25(1):1153 2025 [PMID: 40140785]
  79. Laporte M, Jochmans D, Bardiot D, Desmarets L, Debski-Antoniak OJ, Mizzon G, Abdelnabi R, Leyssen P, Chiu W, Zhang Z, Nomura N, Boland S, Ohto U, Stahl Y, Wuyts J, De Jonghe S, Stevaert A, van Hemert MJ, Bontes BW, Wanningen P, Groenewold GJM, Zegar A, Owczarek K, Joshi S, Koukni M, Arzel P, Klaassen H, Vanherck JC, Vandecaetsbeek I, Cremers N, Donckers K, Francken T, Van Buyten T, Rymenants J, Schepers J, Pyrc K, Hilgenfeld R, Dubuisson J, Bosch BJ, Van Kuppeveld F, Eydoux C, Decroly E, Canard B, Naesens L, Weynand B, Snijder EJ, Belouzard S, Shimizu T, Bartenschlager R, Hurdiss DL, Marchand A, Chaltin P, Neyts J. A coronavirus assembly inhibitor that targets the viral membrane protein Nature 2025 [PMID: 40140569]
  80. Van Damme E, Abeywickrema P, Yin Y, Xie J, Jacobs S, Mann MK, Doijen J, Miller R, Piassek M, Marsili S, Subramanian M, Gottlieb L, Abdelnabi R, Van Gool M, Van den Broeck N, De Pauw I, Diels A, Vermeulen P, Temmerman K, Scobey T, Mattocks M, Schäfer A, Jochmans D, De Jonghe S, Leyssen P, Chiu W, Diosa Toro M, Zwaagstra M, Leijs AA, De Gruyter HLM, Buyck C, Van Den Heede K, Jacobs F, Van den Eynde C, Thijs L, Raeymaekers V, Miller S, Del Rosario A, Neyts J, Peeters D, Baric RS, van Kuppeveld FJM, Snijder EJ, van Hemert MJ, Monshouwer M, Sharma S, Draghia-Akli R, Koul A, Van Loock M. A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein Nature 2025 [PMID: 40140563]
  81. Jia S, Liu Y, He Q, Pan H, Liang Z, Zhou J, Pan Y, Liu S, Wu J, Yang K, Zhang X, Zhao Y, Li S, Zhang L, Chen L, Yao A, Lu M, Zhu F, Mao Q, Li J. Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China Nature communications 16(1):2969 2025 [PMID: 40140382]
  82. Sukik L, Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt A, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities BMJ open respiratory research 12(1) 2025 [PMID: 40139840]
  83. Amodan BO, Okumu PT, Kamulegeya J, Ndyabakira A, Amanya G, Emong DJ, Byaruhanga A, Morukileng J, Ario AR. Knowledge, attitudes and barriers to uptake of COVID-19 vaccine in Uganda, February 2021 BMJ global health 10(3) 2025 [PMID: 40139799]
  84. Farronato A, Travaglia C, Ravasin A, Aprile V, Corzani R, Sicolo E, Peris A, Romagnoli S, Lucchi M, Paladini P, Voltolini L, Gonfiotti A. COVID-19 patients with spontaneous pneumothorax: a propensity-matched, multicentre case-control study Interdisciplinary cardiovascular and thoracic surgery 2025 [PMID: 40139717]
  85. Makoana KM, Naidoo CM, Zubair MS, Motshudi MC, Mkolo NM. Integration of metabolomics and chemometrics with in-silico and in-vitro approaches to unravel SARS-Cov-2 inhibitors from South African plants PloS one 20(3):e0320415 2025 [PMID: 40138368]
  86. Nikbakht F, Heidarian Miri H, Mosafarkhani E, Sharifjafari F, Taghipour A. Role of COVID-19 infection status on the prediction of future infection: Immunity or susceptibility PloS one 20(3):e0317959 2025 [PMID: 40138353]
  87. Li P, Faraone JN, Hsu CC, Chamblee M, Liu Y, Zheng Y-M, Xu Y, Carlin C, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Bednash JS, Xu K, Liu S-L. Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants mBio :e0046425 2025 [PMID: 40136024]
  88. Jana ID, Kanjo K, Roy S, Bhasin M, Bhattacharya S, Banerjee I, Jana S, Chatterjee A, Chakrabarti AK, Chakraborty S, Mukherjee B, Varadarajan R, Mondal A. Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants Journal of virology :e0005125 2025 [PMID: 40135898]
  89. Li P, Faraone JN, Hsu CC, Chamblee M, Liu Y, Zheng Y-M, Xu Y, Carlin C, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Bednash JS, Xu K, Liu S-L. Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability Journal of virology :e0024225 2025 [PMID: 40135879]
  90. Khatami SS, Ghorbani Shirkouhi S, Høilund-Carlsen PF, Revheim ME, Alavi A, Blaabjerg M, Andalib S. Peripheral Nervous System Complications after COVID-19 Vaccination Journal of integrative neuroscience 24(3):26632 2025 [PMID: 40152570]
  91. Ayuk HS, Pierzchalski A, Tal T, Myhre O, Lindeman B, Smith NM, Stojanovska V, Zenclussen AC. Evaluating PFAS-Induced modulation of peripheral blood mononuclear cells (PBMCs) immune response to SARS-CoV-2 spike in COVID-19 Vaccinees Environment international 198:109409 2025 [PMID: 40147139]
  92. Akram S, Aftab R, Baloch QB, Ullah F, Alonazi WB, Baloch VQ, Amin H, Alam MS. The conditionality of COVID-19 vaccine acceptance: A qualitative study in Pakistan African journal of reproductive health 29(3):143-159 2025 [PMID: 40135475]
  93. Pinheiro MG, Alves GGO, Conde MER, Costa SL, Sant'Anna RCS, Antunes IMF, Carneiro MC, Ronzei FS, Scaffo JC, Pinheiro FR, Andre LS, Povoa HC, Baltar VT, Giordani F, Hemerly ES, Alexandre GC, de Paula KC, Watanabe M, da Nóbrega ACL, Lobato JCP, Aguiar-Alves F. Serological surveillance for SARS-CoV-2 antibodies among students, faculty and staff within a large university system during the pandemic World journal of virology 14(1):100338 2025 [PMID: 40134842]
  94. He MZ, Zhang HT, Yang Y, Fang Y, Zhang M, Deng SQ, Sun X. Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control Malaria journal 24(1):99 2025 [PMID: 40133914]
  95. Khales P, Razizadeh MH, Ghorbani S, Moattari A, Saadati H, Tavakoli A. Prevalence of respiratory viruses in children with respiratory tract infections during the COVID-19 pandemic era: a systematic review and meta-analysis BMC pulmonary medicine 25(1):135 2025 [PMID: 40133851]
  96. Palmowski L, Hagedorn A, Witowski A, Haberl H, Kraft F, Achtzehn U, Kindgen-Milles D, Zacharowski K, Nierhaus A, Dietrich M, Mirakaj V, Koch T, Meybohm P, Adamzik M, Bergmann L, Rahmel T. Persistent mortality in critical COVID-19 ICU cases from wild-type to delta variant: A descriptive cohort study Scientific reports 15(1):10191 2025 [PMID: 40133364]
  97. Lee SN, Kim YI, Kim J, Haluwana DK, Eun R, Park SH, Heo J, Gil J, Seong Y, Lee MH, Noh YW, Lee JS, Choi YK, Lim YT. Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models Nature communications 16(1):2914 2025 [PMID: 40133260]
  98. Ladeira F, Nobrega C, Cerqueira J. Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study Journal of neurology 272(4):288 2025 [PMID: 40131515]
  99. Dadonaite B, Burrell AR, Logue J, Chu HY, Payne DC, Haslam DB, Staat MA, Bloom JD. SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals Journal of virology :e0010925 2025 [PMID: 40130874]
  100. Chen X, Shi T, Chen F, Xie X, Fang H, Wu Z, Liu Y, Huang Y, Wang Q, Nie G, Xu J, Shao D. Orally Antigen-Engineered Yeast Vaccine Elicits Robust Intestinal Mucosal Immunity ACS nano 19(11):10841-10853 2025 [PMID: 40082064]

See more by clicking HERE


** Click HERE to see the latest publications in this month.